Back to top
more

PAREXEL International Corporation (PRXL)

(Delayed Data from NSDQ)

$88.08 USD

88.08
6,906,178

-0.02 (-0.02%)

Updated Sep 29, 2017 03:59 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

NA

Industry: NA

Better trading starts here.

Zacks News

PAREXEL's Acquisition by Pamplona Approved by Shareholders

The long-awaited PAREXEL (PRXL) acquisition by Pamplona Capital Management finally receives shareholders' approval. Moreover, the company plans to go private post-acquisition.

    Ride Out MedTech Volatility With These 3 Ultra-Safe Stocks

    In view of the current political scenario and banking on favorable metrics, these three low-beta MedTech stocks stand out as the most suitable value picks.

      PAREXEL Ties Up With Osaka International Cancer Institute

      We believe tie-ups like these will help PAREXEL (PRXL) drive its top and bottom line. The company also has a competitive edge in the Asia-Pacific markets.

        Healthcare Q2 Earnings Due on Aug 2: HUM, PRXL, MOH, TDOC

        The Medical sector is likely to benefit from inorganic growth, product launches, technology upgrades. However, regulatory hassles might offset its growth potential.

          PAREXEL (PRXL) Gets CEO Cancer Gold Standard Accreditation

          PAREXEL International Corporation (PRXL) was recently nominated as a CEO Cancer Gold Standard employer by CEO Roundtable on Cancer.

            Company News for June 21, 2017

            Companies in the News are: TSLA,LEN,PRXL,NK

              PAREXEL Announces Acquisition by Pamplona Capital for $5B

              PAREXEL International Corporation (PRXL) recently announced that it has agreed to be acquired by Pamplona Capital Management, LLP.

                PAREXEL to Launch Connected Journey Data-Driven Services

                PAREXEL International Corporation (PRXL) recently announced the launch of its proprietary data-driven services, Connected Journey.

                  PAREXEL (PRXL) Launches Sensor for Clinical Trial Market

                  PAREXEL International Corporation (PRXL), a global biopharmaceutical services company and provider of clinical research and logistics, recently announced the launch of its patient sensor solution.

                    Falling Earnings Estimates Signal Weakness Ahead for PAREXEL (PRXL)

                    PAREXEL (PRXL) is one stock you should avoid as it has seen a significant price decline and negative earnings estimate revisions.

                      PAREXEL (PRXL): Moving Average Crossover Alert

                      Are you a technical investor? If so, it may be time to consider PAREXEL International Corporation (PRXL) for your portfolio.